Tango Therapeutics Ownership 2024 | Who Owns Tango Therapeutics Now?
Institutional Ownership
20.56%
Insider Ownership
12.87%
Retail Ownership
66.56%
Institutional Holders
34.00
Tango Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TRV GP IV, LLC | 17.75% | 81.48% | 19,201,475 | - | - | 164,748,656 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 12.32% | 3.50% | 13,330,736 | - | - | 114,377,715 | Jun 30, 2024 |
| FMR LLC | 8.70% | 0.01% | 9,409,078 | -82,577 | -0.87% | 80,729,889 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 7.58% | 3.70% | 8,198,642 | - | - | 70,344,348 | Jun 30, 2024 |
| NEXTECH INVEST LTD. | 5.12% | 7.99% | 5,533,980 | - | - | 47,481,548 | Jun 30, 2024 |
| SOUTHPOINT CAPITAL ADVISORS LP | 4.88% | 1.13% | 5,276,699 | - | - | 45,274,077 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 4.40% | 0.03% | 4,755,979 | 434,428 | 10.05% | 40,807,000 | Jun 30, 2024 |
| BLACKROCK INC. | 3.69% | 0.00% | 3,987,852 | 126,490 | 3.28% | 34,215,769 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.05% | 0.00% | 3,294,572 | 213,687 | 6.94% | 28,267,429 | Jun 30, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 2.67% | 2.72% | 2,892,663 | - | - | 24,819,049 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.33% | 0.55% | 2,519,841 | 325,000 | 14.81% | 21,620,236 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.12% | 0.04% | 2,294,206 | - | - | 19,684,287 | Jun 30, 2024 |
| STATE STREET CORP | 1.69% | 0.00% | 1,828,259 | -1,037,839 | -36.21% | 15,686,462,000 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1.42% | 0.22% | 1,540,000 | - | - | 13,213,200 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.13% | 0.00% | 1,225,552 | 92,017 | 8.12% | 10,517,484 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 1.10% | 0.78% | 1,188,349 | - | - | 10,196,034 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.97% | 0.79% | 1,049,895 | -300,250 | -22.24% | 9,008,099 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 0.69% | 0.08% | 750,000 | - | - | 6,435,000 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 0.65% | 0.07% | 708,385 | - | - | 6,077,943 | Jun 30, 2024 |
| BESSEMER GROUP INC | 0.65% | 0.01% | 708,384 | - | - | 6,078,000 | Jun 30, 2024 |
Tango Therapeutics's largest institutional shareholder is TRV GP IV, LLC, holding 17.75% of the company's total share outstanding, currently valued at $164.75M. The top 10 institutional shareholders own together 70.15% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TRV GP IV, LLC | 17.75% | 81.48% | 19,201,475 | - | - | 164,748,656 | Jun 30, 2024 |
| MASS GENERAL BRIGHAM, INC | 0.33% | 14.79% | 354,192 | - | - | 3,038,967 | Jun 30, 2024 |
| NEXTECH INVEST LTD. | 5.12% | 7.99% | 5,533,980 | - | - | 47,481,548 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 7.58% | 3.70% | 8,198,642 | - | - | 70,344,348 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 12.32% | 3.50% | 13,330,736 | - | - | 114,377,715 | Jun 30, 2024 |
| BRASLYN LTD. | 0.02% | 2.77% | 26,961 | - | - | 231,325 | Jun 30, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 2.67% | 2.72% | 2,892,663 | - | - | 24,819,049 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.11% | 1.25% | 115,571 | 115,571 | 100.00% | 991,599 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 0.58% | 1.13% | 630,000 | - | - | 5,405,400 | Jun 30, 2024 |
| SOUTHPOINT CAPITAL ADVISORS LP | 4.88% | 1.13% | 5,276,699 | - | - | 45,274,077 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.97% | 0.79% | 1,049,895 | -300,250 | -22.24% | 9,008,099 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 1.10% | 0.78% | 1,188,349 | - | - | 10,196,034 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.33% | 0.55% | 2,519,841 | 325,000 | 14.81% | 21,620,236 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1.42% | 0.22% | 1,540,000 | - | - | 13,213,200 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.14% | 0.15% | 150,274 | - | - | 1,289,351 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 0.69% | 0.08% | 750,000 | - | - | 6,435,000 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 0.65% | 0.07% | 708,385 | - | - | 6,077,943 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.01% | 0.05% | 10,790 | 2,288 | 26.91% | 92,578 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.12% | 0.04% | 2,294,206 | - | - | 19,684,287 | Jun 30, 2024 |
| ALAETHES WEALTH LLC | 0.01% | 0.04% | 10,000 | - | - | 85,800 | Jun 30, 2024 |
The largest Tango Therapeutics shareholder by % of total assets is TRV GP IV, LLC. The company owns 19.20M shares of Tango Therapeutics (TNGX), representing 81.48% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 0.41% | 0.01% | 447,107 | 447,107 | 100.00% | 3,836,176 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 4.40% | 0.03% | 4,755,979 | 434,428 | 10.05% | 40,807,000 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.32% | 0.03% | 348,091 | 348,091 | 100.00% | 2,986,621 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.33% | 0.55% | 2,519,841 | 325,000 | 14.81% | 21,620,236 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.26% | 0.00% | 277,009 | 277,009 | 100.00% | 2,376,737 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.05% | 0.00% | 3,294,572 | 213,687 | 6.94% | 28,267,429 | Jun 30, 2024 |
| CONGRESS ASSET MANAGEMENT CO /MA | 0.20% | 0.01% | 211,170 | 211,170 | 100.00% | 1,811,839 | Jun 30, 2024 |
| BLACKROCK INC. | 3.69% | 0.00% | 3,987,852 | 126,490 | 3.28% | 34,215,769 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.11% | 1.25% | 115,571 | 115,571 | 100.00% | 991,599 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.31% | 0.00% | 335,913 | 100,257 | 42.54% | 2,881,887 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.13% | 0.00% | 1,225,552 | 92,017 | 8.12% | 10,517,484 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.07% | 0.00% | 78,722 | 66,522 | 545.26% | 675,435 | Jun 30, 2024 |
| MORGAN STANLEY | 0.23% | 0.00% | 243,369 | 63,850 | 35.57% | 2,088,106 | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | 0.13% | 0.00% | 138,247 | 57,115 | 70.40% | 1,186,159 | Jun 30, 2024 |
| FISHER ASSET MANAGEMENT, LLC | 0.14% | 0.00% | 154,947 | 54,256 | 53.88% | 1,329,445 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.05% | 0.00% | 49,753 | 49,753 | 100.00% | 426,880 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.38% | 0.00% | 410,697 | 31,220 | 8.23% | 3,523,780 | Jun 30, 2024 |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 0.03% | 0.00% | 28,380 | 28,380 | 100.00% | 243,500 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.06% | 0.01% | 62,417 | 28,155 | 82.18% | 535,538 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.02% | 0.00% | 25,666 | 25,666 | 100.00% | 220,214 | Jun 30, 2024 |
As of Jun 30 2024, Tango Therapeutics's largest institutional buyer is POINT72 ASSET MANAGEMENT, L.P.. The company purchased 447.11K stocks of TNGX, valued at $3.84M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 1.69% | 0.00% | 1,828,259 | -1,037,839 | -36.21% | 15,686,462,000 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.97% | 0.79% | 1,049,895 | -300,250 | -22.24% | 9,008,099 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.25% | 0.00% | 271,822 | -234,560 | -46.32% | 2,332,233 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.08% | 0.00% | 90,778 | -216,457 | -70.45% | 778,875 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -196,384 | -100.00% | - | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | - | - | - | -168,400 | -100.00% | - | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.07% | 0.00% | 72,889 | -147,130 | -66.87% | 625,388 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.19% | 0.00% | 205,270 | -143,066 | -41.07% | 1,761,216 | Jun 30, 2024 |
| BARCLAYS PLC | 0.07% | 0.00% | 70,811 | -112,675 | -61.41% | 608,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -109,269 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | 8.70% | 0.01% | 9,409,078 | -82,577 | -0.87% | 80,729,889 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.05% | - | 51,559 | -71,138 | -57.98% | 442,377 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | - | -67,115 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -65,600 | -100.00% | - | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | - | - | - | -58,180 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.01% | 0.00% | 14,158 | -51,040 | -78.28% | 121,476 | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -50,894 | -100.00% | - | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.04% | 0.00% | 38,201 | -47,960 | -55.66% | 327,765 | Jun 30, 2024 |
| INTEGRITY WEALTH SOLUTIONS LLC | - | - | - | -33,199 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -30,429 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Tango Therapeutics's biggest institutional seller is STATE STREET CORP. The company sold -1.04M shares of TNGX, valued at $15.69B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 0.41% | 0.01% | 447,107 | 447,107 | 100.00% | 3,836,176 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.32% | 0.03% | 348,091 | 348,091 | 100.00% | 2,986,621 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.26% | 0.00% | 277,009 | 277,009 | 100.00% | 2,376,737 | Jun 30, 2024 |
| CONGRESS ASSET MANAGEMENT CO /MA | 0.20% | 0.01% | 211,170 | 211,170 | 100.00% | 1,811,839 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.11% | 1.25% | 115,571 | 115,571 | 100.00% | 991,599 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.05% | 0.00% | 49,753 | 49,753 | 100.00% | 426,880 | Jun 30, 2024 |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 0.03% | 0.00% | 28,380 | 28,380 | 100.00% | 243,500 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.02% | 0.00% | 25,666 | 25,666 | 100.00% | 220,214 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 25,522 | 25,522 | 100.00% | 218,869 | Jun 30, 2024 |
| BLEAKLEY FINANCIAL GROUP, LLC | 0.01% | 0.00% | 16,080 | 16,080 | 100.00% | 137,966 | Jun 30, 2024 |
| QUARRY LP | 0.01% | 0.03% | 11,500 | 11,500 | 100.00% | 98,670 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 0.01% | 0.00% | 10,497 | 10,497 | 100.00% | 90,065,000 | Jun 30, 2024 |
| CASTLEVIEW PARTNERS, LLC | 0.01% | 0.03% | 6,944 | 6,944 | 100.00% | 59,580 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.01% | 0.00% | 6,281 | 6,281 | 100.00% | 53,893 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 2,446 | 2,446 | 100.00% | 20,987 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 819 | 819 | 100.00% | 7,027 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 30 | 30 | 100.00% | 257 | Jun 30, 2024 |
Tango Therapeutics's largest new institutional shareholder by number of shares is POINT72 ASSET MANAGEMENT, L.P., purchased 447.11K shares, valued at $3.84M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -196,384 | -100.00% | - | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | - | - | - | -168,400 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -109,269 | -100.00% | - | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | - | -67,115 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -65,600 | -100.00% | - | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | - | - | - | -58,180 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -50,894 | -100.00% | - | Jun 30, 2024 |
| INTEGRITY WEALTH SOLUTIONS LLC | - | - | - | -33,199 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -30,429 | -100.00% | - | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -24,405 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -22,001 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -21,494 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -21,338 | -100.00% | - | Jun 30, 2024 |
| STRS OHIO | - | - | - | -15,900 | -100.00% | - | Jun 30, 2024 |
| CORTON CAPITAL INC. | - | - | - | -15,779 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -13,172 | -100.00% | - | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | - | - | - | -12,296 | -100.00% | - | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | - | - | - | -11,467 | -100.00% | - | Jun 30, 2024 |
| MARINER, LLC | - | - | - | -10,897 | -100.00% | - | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -10,398 | -100.00% | - | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | - | - | - | -10,040 | -100.00% | - | Jun 30, 2024 |
| MIRABELLA FINANCIAL SERVICES LLP | - | - | - | -10,040 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,484 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -2,349 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -12 | -100.00% | - | Jun 30, 2024 |
Tango Therapeutics's largest sold out institutional shareholder by shares sold is CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD., sold -0.20M shares, valued at -, as of undefined.
Tango Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.26% | 950,522 | 950,522 | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.16% | 1,221,646 | 1,221,646 | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.06% | 167,744 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.06% | 1,634,597 | -93,988 | -5.44% | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 25,100 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.05% | 406,869 | -277,100 | -40.51% | Jan 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.04% | 443,992 | 443,992 | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.03% | 8,720 | - | - | Mar 31, 2024 |
| Vericimetry Funds | 0.03% | 2,920 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.03% | 62,214 | 62,214 | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,880,795 | -48,200 | -2.50% | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 52,526 | 16,292 | 44.96% | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 79,367 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 6,929 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 85,524 | - | - | Jan 31, 2024 |
| Nushares ETF Trust | 0.01% | 48,984 | -7,433 | -13.18% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,495,483 | -716,671 | -22.31% | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 8,054 | 8,054 | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,233 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 310,288 | -253,500 | -44.96% | Feb 29, 2024 |
| ALPS ETF Trust | 0.00% | 55,653 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 120,295 | -3,158 | -2.56% | Jan 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 40,951 | 40,951 | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 496,201 | 18,805 | 3.94% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 4,378 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 116,371 | -309,325 | -72.66% | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 38,490 | -9,470 | -19.75% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 35,263 | -2,961 | -7.75% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 348,759 | 39,064 | 12.61% | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 20,644 | -3,348 | -13.95% | Jan 31, 2024 |
| ProFunds | 0.00% | 11,517 | 11,142 | 2971.20% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 19,383 | 3,106 | 19.08% | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 170,907 | -57,145 | -25.06% | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 73,550 | 18,901 | 34.59% | Feb 29, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 1,025 | 1,025 | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 138,319 | -16,394 | -10.60% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 14,728 | -3,721 | -20.17% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 255,866 | 8,742 | 3.54% | Feb 29, 2024 |
| Global X Funds | 0.00% | 19,290 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,018 | -330 | -14.05% | Mar 31, 2024 |
| Series Portfolios Trust | 0.00% | 2,334 | 2,252 | 2746.34% | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 905 | -928 | -50.63% | Mar 31, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 5,054 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 15,700 | 900 | 6.08% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 2,787 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 20,072 | 8 | 0.04% | Mar 28, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 8,157 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 2,065,422 | -100,995 | -4.66% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 2,784 | 144 | 5.45% | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 44,267 | 12,272 | 38.36% | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 126,017 | 11,142 | 9.70% | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 110,913 | -10,642 | -8.75% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 196,367 | 21,462 | 12.27% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 407 | - | - | Dec 31, 2023 |
| Dimensional ETF Trust | 0.00% | 40,832 | 36,320 | 804.96% | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 246,481 | 156,049 | 172.56% | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 9,593 | 2,925 | 43.87% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 17,132 | -69 | -0.40% | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 14,164 | 1,894 | 15.44% | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 24,030 | - | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,500 | - | - | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 202 | - | - | Dec 31, 2023 |
| SPDR SERIES TRUST | 0.00% | 1,833,119 | 1,833,119 | - | Mar 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 5,120 | - | - | Mar 28, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 43,302 | 7,362 | 20.48% | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 4,691 | 3 | 0.06% | Jan 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,710 | - | - | Dec 31, 2023 |
| Two Roads Shared Trust | 0.00% | 1,183 | -759 | -39.08% | Jan 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 86,416 | - | - | Dec 31, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 59,301 | -3,182 | -5.09% | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 27 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 16,583 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,743 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 5,058 | -20 | -0.39% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 814 | - | - | Feb 29, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 2,411 | 135 | 5.93% | Mar 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 37,133 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 18,264 | 314 | 1.75% | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 33,066 | -1,104 | -3.23% | Mar 31, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 28,860 | - | - | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 18,584 | -674 | -3.50% | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 18,706 | - | - | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 161 | 34 | 26.77% | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 5,414 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 6,412 | -111 | -1.70% | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 5,628 | -941 | -14.32% | Jan 31, 2024 |
| FIDELITY SUMMER STREET TRUST | 0.00% | 234 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 5,100 | - | - | Feb 29, 2024 |
Tango Therapeutics's largest mutual fund holder by % of total assets is "T. Rowe Price Small-Cap Stock Fund, Inc.", owning 950.52K shares, compromising 0.26% of its total assets.
Tango Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 34 | -73.02% |
| 31 Mar, 24 | 126 | 5.88% |
| 31 Dec, 23 | 119 | 19.00% |
| 30 Sep, 23 | 100 | 12.36% |
| 30 Jun, 23 | 89 | -2.20% |
| 31 Mar, 23 | 91 | 10.98% |
| 31 Dec, 22 | 82 | -4.65% |
| 30 Sep, 22 | 86 | 13.16% |
| 30 Jun, 22 | 76 | 7.04% |
| 31 Mar, 22 | 71 | 24.56% |
| 31 Dec, 21 | 57 | 23.91% |
| 30 Sep, 21 | 46 | - |
As of 30 Jun 24, 34 institutions are holding Tango Therapeutics's shares, representing a decrease of -73.02% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 22,242,878 | -77.39% |
| 31 Mar, 24 | 98,397,257 | 5.09% |
| 31 Dec, 23 | 93,633,433 | 5.42% |
| 30 Sep, 23 | 88,816,122 | 30.00% |
| 30 Jun, 23 | 68,320,894 | -2.16% |
| 31 Mar, 23 | 69,826,319 | 1.57% |
| 31 Dec, 22 | 68,748,778 | 0.87% |
| 30 Sep, 22 | 68,154,877 | -3.26% |
| 30 Jun, 22 | 70,452,286 | 1.11% |
| 31 Mar, 22 | 69,680,162 | 2.81% |
| 31 Dec, 21 | 67,775,217 | 3.41% |
| 30 Sep, 21 | 65,540,219 | - |
Tango Therapeutics (TNGX) has 22.24M shares outstanding as of 30 Jun 24, down -77.39% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 20.56% | 0.25% |
| 31 Mar, 24 | 90.96% | 0.98% |
| 31 Dec, 23 | 96.31% | 1.15% |
| 30 Sep, 23 | 91.53% | 1.53% |
| 30 Jun, 23 | 77.33% | 1.23% |
| 31 Mar, 23 | 79.17% | 1.29% |
| 31 Dec, 22 | 78.28% | 1.30% |
| 30 Sep, 22 | 77.54% | 1.21% |
| 30 Jun, 22 | 80.21% | 1.27% |
| 31 Mar, 22 | 79.48% | 0.67% |
| 31 Dec, 21 | 109.12% | 1.25% |
| 30 Sep, 21 | 93.41% | - |
As of 30 Jun 24, Tango Therapeutics is held by 20.56% institutional shareholders, representing a 0.25% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 17 | -70.69% |
| 31 Mar, 24 | 58 | -22.67% |
| 31 Dec, 23 | 75 | 36.36% |
| 30 Sep, 23 | 55 | 66.67% |
| 30 Jun, 23 | 33 | -21.43% |
| 31 Mar, 23 | 42 | - |
| 31 Dec, 22 | 42 | - |
| 30 Sep, 22 | 42 | -19.23% |
| 30 Jun, 22 | 52 | 23.81% |
| 31 Mar, 22 | 42 | 35.48% |
| 31 Dec, 21 | 31 | -32.61% |
| 30 Sep, 21 | 46 | - |
17 institutional shareholders have increased their position in TNGX stock as of 30 Jun 24 compared to 58 in the previous quarter (a -70.69% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 8 | -78.95% |
| 31 Mar, 24 | 38 | 72.73% |
| 31 Dec, 23 | 22 | -15.38% |
| 30 Sep, 23 | 26 | -16.13% |
| 30 Jun, 23 | 31 | 34.78% |
| 31 Mar, 23 | 23 | 9.52% |
| 31 Dec, 22 | 21 | 16.67% |
| 30 Sep, 22 | 18 | 80.00% |
| 30 Jun, 22 | 10 | -9.09% |
| 31 Mar, 22 | 11 | 37.50% |
| 31 Dec, 21 | 8 | - |
| 30 Sep, 21 | - | - |
8 institutional shareholders have reduced their position in TNGX stock as of 30 Jun 24 compared to 38 in the previous quarter (a -78.95% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 34 | -73.02% | 22,242,878 | -77.39% | 20.56% | 0.25% | 17 | -70.69% | 8 | -78.95% |
| 31 Mar, 24 | 126 | 5.88% | 98,397,257 | 5.09% | 90.96% | 0.98% | 58 | -22.67% | 38 | 72.73% |
| 31 Dec, 23 | 119 | 19.00% | 93,633,433 | 5.42% | 96.31% | 1.15% | 75 | 36.36% | 22 | -15.38% |
| 30 Sep, 23 | 100 | 12.36% | 88,816,122 | 30.00% | 91.53% | 1.53% | 55 | 66.67% | 26 | -16.13% |
| 30 Jun, 23 | 89 | -2.20% | 68,320,894 | -2.16% | 77.33% | 1.23% | 33 | -21.43% | 31 | 34.78% |
| 31 Mar, 23 | 91 | 10.98% | 69,826,319 | 1.57% | 79.17% | 1.29% | 42 | - | 23 | 9.52% |
| 31 Dec, 22 | 82 | -4.65% | 68,748,778 | 0.87% | 78.28% | 1.30% | 42 | - | 21 | 16.67% |
| 30 Sep, 22 | 86 | 13.16% | 68,154,877 | -3.26% | 77.54% | 1.21% | 42 | -19.23% | 18 | 80.00% |
| 30 Jun, 22 | 76 | 7.04% | 70,452,286 | 1.11% | 80.21% | 1.27% | 52 | 23.81% | 10 | -9.09% |
| 31 Mar, 22 | 71 | 24.56% | 69,680,162 | 2.81% | 79.48% | 0.67% | 42 | 35.48% | 11 | 37.50% |
| 31 Dec, 21 | 57 | 23.91% | 67,775,217 | 3.41% | 109.12% | 1.25% | 31 | -32.61% | 8 | - |
| 30 Sep, 21 | 46 | - | 65,540,219 | - | 93.41% | - | 46 | - | - | - |
Tango Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Tango Therapeutics's stock was made by Third Rock Ventures IV, L.P. on Aug 01 2024, selling 95,000 shares at $9.80 per share (valued at $931.11K).
Tango Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 12 | - |
| Q2 2024 | 11 | 6 | 183.33% |
| Q1 2024 | 8 | 9 | 88.89% |
| Q4 2023 | 4 | 3 | 133.33% |
| Q3 2023 | 6 | 1 | 600.00% |
| Q2 2023 | 12 | - | - |
| Q1 2023 | 10 | - | - |
| Q4 2022 | 15 | - | - |
| Q2 2022 | 9 | - | - |
| Q1 2022 | 4 | - | - |
| Q4 2021 | 1 | 1 | 100.00% |
| Q3 2021 | 3 | 23 | 13.04% |
| Q4 2020 | - | 2 | - |
| Q3 2020 | 1 | 4 | 25.00% |
0 total buy trades, and 12 total sell trades (buy/sell ratio of 0.00%) were made by Tango Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 12 | - |
| Q2 2024 | - | 7 | - |
| Q1 2024 | - | 9 | - |
| Q4 2023 | 4 | 3 | 133.33% |
| Q3 2023 | 2 | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 14 | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q4 2020 | - | 2 | - |
| Q3 2020 | 1 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 12 open market sell trades of Tango Therapeutics's stocks.
Tango Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| PLRX | Pliant Therapeutics, Inc. |
| NRIX | Nurix Therapeutics, Inc. |
| KYMR | Kymera Therapeutics, Inc. |
| ARVN | Arvinas, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| FHTX | Foghorn Therapeutics Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| RLAY | Relay Therapeutics, Inc. |
| BCEL | Atreca, Inc. |
| TYRA | Tyra Biosciences, Inc. |
| RLYB | Rallybio Corporation |
| CNTB | Connect Biopharma Holdings Limited |
| PASG | Passage Bio, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| THRD | Third Harmonic Bio, Inc. |
| XLO | Xilio Therapeutics, Inc. |
| STTK | Shattuck Labs, Inc. |
| RAPT | RAPT Therapeutics, Inc. |
TNGX Ownership FAQ
Who Owns Tango Therapeutics?
Tango Therapeutics is owned by institutional shareholders (20.56%), insiders (12.87%), and public (66.56%). The largest institutional shareholder of Tango Therapeutics is TRV GP IV, LLC (17.75% of total shares) and the top mutual fund owner is T. Rowe Price Small-Cap Stock Fund, Inc. (0.26% of total shares).
Who are the major institutional shareholders of Tango Therapeutics?
Tango Therapeutics's major institutional shareholders are TRV GP IV, LLC, ECOR1 CAPITAL, LLC, FMR LLC, BOXER CAPITAL, LLC, and NEXTECH INVEST LTD.. The top five shareholders own together 51.47% of the company's share outstanding.
How many Tango Therapeutics shareholders are there?
As of Jun 2024, there are 34 institutional shareholders of Tango Therapeutics.
What percentage of Tango Therapeutics is owned by TRV GP IV, LLC?
TRV GP IV, LLC owns 19.2M shares of Tango Therapeutics, representing 17.75% of the company's total shares outstanding, valued at $164.75M (as of Jun 2024).
What percentage of Tango Therapeutics is owned by ECOR1 CAPITAL, LLC?
As of Jun 2024, ECOR1 CAPITAL, LLC holds 13.33M shares of Tango Therapeutics (TNGX), compromising 12.32% of the company, valued at $114.38M.
What percentage of Tango Therapeutics is owned by FMR LLC?
FMR LLC is the third largest holder of Tango Therapeutics. The company owns 9.41M of the company's shares outstanding (worth $80.73M).